CabaƱas, Rezamie .
HRN: 26-23-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2024
CEFUROXIME 500MG (TAB)
11/24/2024
12/01/2024
PO
500mg
1 Tab Bid X 7 Days
S/p Cs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes